If your dog has seizures, the internet knows. The targeted ads arrive fast, and they are confident: CBD oil, they suggest, is the natural answer that will calm the storms in your dog’s brain. It is an appealing message, especially when you have just watched your dog convulse and felt completely powerless.
Here is the uncomfortable, important truth. For seizures specifically, that confidence is not earned. The marketing is running well ahead of the evidence, and a dog with a serious neurological condition is exactly the wrong place to trust a supplement over established medicine. Let us walk through what is actually known, because the honest picture is more useful than the hopeful one.
First, what a seizure actually is
A seizure is a burst of abnormal electrical firing among neurons, mostly in the brain’s cerebral cortex. The causes are varied: epilepsy, head injury, toxins, infections, genetic disease, brain tumors, or systemic problems like high fever, low blood sugar, or liver disease.
Seizures come in types. Generalized (grand mal) seizures are the dramatic kind people picture from television, a dog collapsing, losing consciousness, tremoring or paddling its limbs, sometimes losing bladder or bowel control. Focal seizures and psychomotor seizures look different and can be subtler. Most seizures include an aura, an odd change in behavior beforehand, and a post-ictal period afterward when the dog seems dazed or “off.”
Vets also sort seizures by likely cause. Primary seizures have no clear trigger; idiopathic epilepsy is the classic example, usually first appearing in dogs between six months and five years old, and most affected dogs need lifelong medication. Secondary seizures stem from a diagnosed brain abnormality like a tumor or old head injury. Reactive seizures come from problems outside the brain, such as a toxin or liver failure, and often resolve when the underlying illness is treated. Pinning down which type your dog has can require a neurology referral and advanced imaging like a CT or MRI, which is not available or affordable for everyone, so vets often treat the most likely cause based on exam, age, and other tests.
“The first thing I tell a worried owner is that a seizing dog is a medical situation, not a supplement situation,” says Dr. Ravi Mehta. “Uncontrolled or prolonged seizures can cause real, permanent brain damage. That’s why we reach for medications with decades of evidence behind them, and why I get uneasy when someone tells me they’re managing their dog’s epilepsy with an oil they bought online instead.”
Why traditional medication still leads
Anti-seizure drugs aim to reduce how often and how severely seizures happen. They matter because seizures themselves are dangerous; a seizure lasting more than a few minutes, or clusters of frequent seizures, a state called status epilepticus, can cause irreversible harm. Controlling them is not optional.
Common options include phenobarbital, levetiracetam (Keppra), potassium bromide, and zonisamide. They can cause sedation, especially during the initial loading period, though that usually eases with time. Some require monitoring: dogs on phenobarbital or potassium bromide need periodic blood tests to keep the dose in the safe range. These drugs are not a cure, they control the condition, so they only work while they are given as prescribed. Stop them, and the seizures return unless the underlying cause has been resolved.
What the CBD research actually shows
Now the part the ads skip. In humans, CBD has genuinely promising results for seizures, but mainly for specific rare genetic epilepsy syndromes, which is what led to the FDA-approved drug Epidiolex. That success is real, and it is what inspired researchers to test CBD in dogs. It does not automatically carry over.
In dogs, the evidence is thin and mixed. There is a small study from Colorado State University in which some dogs improved when CBD was added to their standard anti-seizure medication. But the study was small, and, tellingly, dogs in the placebo group, getting only traditional medication, showed similar improvement. When the placebo does about as well as the treatment, it is very hard to say the CBD did anything. Overall, CBD has not been shown to reduce seizures in dogs, particularly in dogs already breaking through on standard drugs. To date there are no studies showing CBD oil alone controls canine seizures, and there is no defined therapeutic dose, meaning nobody has established how much a dog would even need for a benefit, if one exists.
The one genuinely reassuring finding is safety. CBD has a wide therapeutic index, so it is relatively hard to reach a dangerous dose. Toxicity studies suggest that at around 2 mg per kilogram of body weight, roughly 9 mg total for a 10-pound dog, side effects are minimal and tend to be things like nausea, vomiting, or diarrhea. Higher doses raise the risk of more serious effects, including drooling, dehydration, shaking, wobbly walking, and liver problems, so going above that range is not advised.
The product problem nobody advertises
Even setting aside whether CBD works, there is a supply problem. The FDA does not regulate CBD-based pet products, so there is no guaranteed standard for how much CBD is actually in the bottle. Independent analyses of CBD products have repeatedly found the contents do not match the label; one analysis of human CBD products found only about 31 percent contained the amount of CBD claimed. You may be buying far less, or far more, than the label says.
If you do use CBD with your vet’s blessing, a few hard rules apply. Make sure the product contains no THC, which is toxic to dogs and, at that, can increase seizure risk, the opposite of what you want. Confirm the product is formulated for dogs, not people, because human products can contain xylitol, an artificial sweetener that causes liver failure in dogs. And look for third-party lab testing or an NSF certification, which signals the product was actually verified.
What newer research adds
The canine CBD field is still maturing, and the seizure question specifically remains open. Neurologist Stephanie McGrath’s group at Colorado State University has run the most prominent trials; earlier work reported a majority of CBD-treated dogs having fewer seizures, but subsequent randomized controlled trials have shown more modest and variable results, with seizure reductions in roughly a third to under half of treated dogs across studies, which is why enthusiasm remains cautious. A 2025 systematic review of CBD for refractory (hard-to-treat) canine epilepsy reached the same careful conclusion: the results are not yet strong or consistent enough to call CBD an established treatment, and larger, longer trials are needed. Some of those trials are underway.
So where does that leave you? If your dog is having seizures, the first and most important step is a veterinarian, not a shopping cart. Standard anti-seizure medications are effective, well-studied, and, for most dogs, the difference between a manageable condition and a dangerous one. CBD may eventually earn a supporting role, and it is reasonable to ask your vet about it as a complement, not a replacement. But do not let confident advertising talk you into betting your dog’s brain on a bottle the science has not caught up to yet.
Seizures are a medical emergency the first time they happen and any time one lasts more than a few minutes or repeats in clusters. This article is general information, not a treatment plan; decisions about seizure medication and supplements belong with your veterinarian.
References
- “Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol on seizure frequency in dogs with intractable idiopathic epilepsy.” Colorado State University / JAVMA. avmajournals.avma.org
- “Cannabidiol treatment for refractory idiopathic epilepsy in dogs: A systematic review.” The Veterinary Journal, 2025. sciencedirect.com
- “Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge.” Frontiers in Veterinary Science, 2023. frontiersin.org
- U.S. Food and Drug Administration. Veterinary NSAIDs and CBD product safety information. fda.gov
